Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Lantana Awarded General Services Administration Multiple Award Schedule


The General Services Administration (GSA) awarded Lantana Consulting Group a Multiple Award Schedule with Special Item Number (SIN) 54151HEAL – the consolidated solicitation SIN for Health Information Technology Services. Lantana is a small, woman-owned technology consultancy specializing in the provision of information to public health, regulators, payers, and providers via standards-based solutions. The 15-year-old company has broad services that encompass clinical informatics, analytics, and software design and development and a strong reputation for innovation.

“Lantana is pleased to offer its Federal and State clients alternative contract mechanisms,” says Mike Tushan, Director of Business Development, “We look forward to expanding how we help our clients strategically leverage their health information for policy and decision-making.”

The Health Information Technology Services SIN allows federal customers to purchase professional services and labor that improve the quality of healthcare, prevent medical errors, protect data, increase administrative efficiencies, and decrease paperwork.

Lantana is committed to excellence and creating innovative and flexible solutions for Federal clients through work acquired on this multiple award schedule.

About Lantana

Lantana Consulting Group is a leader in health data quality and integration, which increases access to health information across the spectrum of care delivery and management.

For More Information:

Web: http://www.lantanagroup.com

Email: info@lantanagroup.com

Share article on social media or email:

Oncology Firm Ready to Take Next Step on Non-Invasive Cancer Diagnoses, Treatments


When combined with the radionucleotide Cu-64, the peptide analog appears to “light up” on standard imaging studies, such as positron emission tomography (PET) imaging.

Our initial successes using NV-VPAC1 to diagnose prostate cancer would pave the way for the technology to eventually be used for other types of cancer, both rare and more common.

A Utah oncology firm is developing a cancer diagnostic test and treatment delivery system that will make costly—and invasive—biopsies a thing of the past. For the most part, current diagnostic methods are time-consuming and expensive—most doctors order a battery of tests, including lab work, imaging studies, and surgical biopsies, to confirm malignancy.(1) New technology developed by clinical-stage oncology company NuView Life Sciences is poised to influence cancer diagnosis and treatment, helping doctors provide safer, less expensive, and more accurate care to each patient.

“NV-VPAC1(TM) will dramatically alter the way we diagnose and treat cancer,” says Paul Crowe, CEO of NuView Life Sciences. “There is no other technology like it today—the peptide targets a variety of cancer cells with extreme precision, providing a binary approach to cancer diagnosis. We’re working to develop the technology so that NV-VPAC1 will enable doctors to inform patients definitively whether they have cancer or not.”

NV-VPAC1 is a unique proprietary peptide construct that targets a specific receptor, called vasoactive intestinal peptide receptor type 1 (VPAC1), which is over-expressed on the surface of cancer cells. While normal, healthy cells may have a few of these receptors, cancerous cells typically express millions of them, making them an ideal target for new diagnostic and theranostic technologies. Developed by a team of experts to include Dr’s Mathew Thakur, Leonard Gomella, Charalambos Solomides, Edouard Trabulsi from Thomas Jefferson University, and Dr. Jay Bishoff, Urologist with Intermountain Healthcare, and Clinical Collaborator with NuView Life Sciences.

Even more exciting is that this new urine test for prostate cancer, NV-VPAC1, can be combined with Copper-64 (Cu-64), a positron emitter for PET imaging of metastatic prostate cancer and also combined with Copper (Cu-67) to treat prostate cancer, says Dr. Bishoff.

Dr. Bishoff and his colleagues have conducted research using voided urine specimens from men suspected of having prostate cancer after lab work revealed elevated prostate-specific antigen (PSA) levels. Each man included in this initial research received the combination of NV-VPAC1 attached with a fluorescent dye. Then, their urine specimens were examined under a confocal microscope—remarkably, the researchers noted that prostate cancer cells fluoresced under the microscope, while healthy, normal cells did not. Dr. Bishoff also notes that current tests have shown NV-VPAC1 to be extremely precise, with extremely low false positive rates. The next step is to conclude clinical trials and receive FDA approval. This is not an expensive genetic test, but a simple urine test that can be run in the lab and eventually in the doctor’s office at a fraction of the cost of expensive genetic tests.

Beyond the obvious benefits to patients, NV-VPAC1 also helps doctors provide better treatment and improve outcomes. According to Dr. Bishoff, the peptide analog series will:

  • Eliminate unnecessary diagnostic testing. Unlike predictive analysis of specimen samples, NV-VPAC1 uses a binary approach to cancer diagnosis. In the case of prostate cancer, early in vitro studies indicate that voided urine samples are all that is necessary to detect shed prostate or bladder cancer cells.
  • Reduce diagnostic side effects and discomfort. Each year, almost 2 million prostate biopsies are performed in the United States. (2) These procedures are expensive, invasive, and, in some cases, lead to serious complications like sepsis. Doctors may use NV-VPAC1 as a better diagnostic option that poses no risk to the patient. Additionally, since NV-VPAC1 is engineered to detect cancer in voided specimens, there is no need to perform uncomfortable and invasive tests, such as a digital rectal examination, to help confirm a diagnosis.
  • Help doctors tailor treatment to individuals. In many cases, standard cancer treatment methods use a “scorched earth” method—high doses of chemotherapy are given, which kill healthy cells along with cancer cells. Or, part of the patient’s body is bathed in high doses of radioactivity, which also poses harm to the patient. Unlike these methods, NV-VPAC1 can be combined with Cu-67 and target only cancer cells, killing them while preserving healthy tissue. The technology should make it possible for doctors to deliver lower doses of more precise treatments to better serve their patients.
  • Allow doctors to monitor response to treatment. Early in vivo studies show that cancerous cells readily bind to NV-VPAC1. When combined with the radionucleotide Cu-64, the peptide analog appears to “light up” on standard imaging studies, such as positron emission tomography (PET) imaging. This technology can, in turn, be used to monitor a patient’s response to treatment by comparing the size and location of tumors before and after initiation of various therapies.

Dr. Bishoff says, “Other types of cancers, including breast, bladder, and adrenal cancer, also express VPAC1 at high levels. Our initial successes using NV-VPAC1 to diagnose prostate cancer would pave the way for the technology to eventually be used for other types of cancer, both rare and more common.”

Thanks to preliminary testing, NuView Life Sciences is taking NV-VPAC1 into clinical trials to examine the peptide’s accuracy in prostate cancer diagnosis. The study, hosted at Intermountain Healthcare, will recruit 150 patients who are scheduled for prostate biopsy to confirm or rule out prostate cancer. Biopsy results will be compared to the results obtained using NV-VPAC1 to analyze voided urine specimens to determine whether NV-VPAC1 is truly more accurate compared to standard prostate cancer diagnostic methods. Eventually, this clinical trial will expand to include other major medical institutions and universities.

“We’re confident in our technology and the promise it holds for cancer diagnostics and treatment. We hope that, by undergoing clinical trials, we can prove how beneficial NV-VPAC1 will be in avoiding unnecessary procedures, reducing cancer care cost, and providing better outcomes to patients,” says Bishoff.

About NuView Life Sciences

Founded in 2005, NuView Life Sciences is a clinical-stage precision oncology company located in Park City, Utah, advancing the way cancer is diagnosed and treated in our modern healthcare system. NuView is focused on creating precision binary cancer diagnostics and theranostics, providing clinicians more choices to improve patient outcomes while reducing healthcare costs through the development and clinical application of its exclusive proprietary peptide analog technology, NV-VPAC1(TM). Led by a multidisciplinary team of industry experts with decades of combined experience in healthcare and medical imaging technologies, NuView is poised to introduce a new cancer diagnostic technology and subsequently deliver a theranostic approach for effectively treating cancer. To learn more, visit http://www.nuviewlifesciences.com.

1.    “How Cancer Is Diagnosed.” National Cancer Institute, 2020, cancer.gov/about-cancer/diagnosis-staging/diagnosis.

2.    “NuView Diagnostics: In Vitro.” NuView Life Sciences, 2020, nuviewlifesciences.com/diagnostics/in-vitro-diagnostics/.

Share article on social media or email:

Bay State Physical Therapy Opens in Saugus, MA


Bay State Physical Therapy, Massachusetts’ leading provider in outpatient physical therapy services, now open in Saugus, MA.

Bay State Physical Therapy is excited to announce the opening of a new facility in Saugus, MA! The new facility is located at 600 Broadway (Route 1) northbound near Home Depot and Walmart. This clinic will be directed by Bret Ferrell, PT, MSPT, who is also the Managing Partner of Bay State PT offices in Beverly, Salem, and Swampscott. The office is accepting new patients and accepts most insurance plans. Convenient morning and evening hours are available for treatment. The clinic will also have onsite Chiropractic services.

Laura Pempkowski, PT, DPT is the clinical manager of the Saugus clinic. Laura is a proud “double husky” earning both undergraduate and doctorate degrees in Rehabilitation Science and Physical Therapy from Northeastern University. Laura has familiarity with a wide range of musculoskeletal conditions and patient learning styles. Her professional and personal interest in dance has been a consistent area of study throughout her physical therapy education and career.

“I am thrilled to help Bay State extend its strong reputation of high-quality physical therapy to Saugus. Physical therapy outcomes occur as a result of consistency,” says Laura, “Having another site that is convenient for patients makes all the difference in their PT success. Last year, I settled into my new home in Medford. I’m excited to work in a neighboring community and be a local resource for anyone looking to move and feel better!”

Bay State Physical Therapy in Saugus offers care for pre and post-operative rehab, arthritis, tendinitis, balance impairments and post stroke recovery, gait and posture retraining, sciatica, ergonomic assessment, and much more!

Access to care is available with or without a physician’s prescription, as well as through virtual telehealth, The office is open Monday through Thursday from 7:00 am – 7:00 pm, Friday from 7:00 am – 5:00 pm, and Saturdays by appointment. If you’ve injured yourself or are experiencing pain or discomfort, the Bay State Physical Therapy team is here for you. To make an appointment call 781-746-6013 or email Saugus@baystatept.com. To learn more about the Saugus clinic and to request an appointment online please visit our website.

At Bay State Physical Therapy we are taking precautionary measures to make safety our top priority. During the pandemic, we want to ensure a safe environment for patients and staff, following state and Centers for Disease Control (CDC) guidelines as they evolve. We have worked together as a company to redesign our procedures to promote social distancing and maintain a safe environment. Each site has implemented prescreening phone calls, mandatory temperature checks, thorough cleaning procedures, touch-free payments, and all staff and patients wear masks. We have also expanded our service offering to include telehealth appointments. For more information on COVID-19 safety please see the COVID-19 Update webpage on our website.

About Bay State Physical Therapy

Headquartered just outside of Boston, MA, Bay State Physical Therapy (“Bay State”) is a leading provider of physical therapy and chiropractic services throughout New England. Bay State’s mission is to be devoted to the health and wellbeing of our patients by offering exceptional, innovative rehabilitation services, to restore each individual’s maximal function with integrity and compassion. Bay State supports its partners and affiliates by investing in the resources, operating expertise, and systems to allow therapists to focus on the patient and the provision of clinical care.

For career opportunities with Bay State Physical Therapy please visit our Job Opportunities page on https://baystatept.com.

Share article on social media or email:

Costs of Care Presents Steven Schroeder Award for Outstanding Healthcare CEO to Mr. Carl S. Armato at The Leapfrog Group Annual Meeting


Mr. Carl S. Armato, President and CEO of Novant Health, recipient of this year’s Steven Schroeder Award for Outstanding Healthcare CEO

Novant Health exists to improve the health of our communities, one person at a time. – Mr. Armato

The influential Steven Schroeder Award for Outstanding Healthcare CEO was presented virtually at The Leapfrog Group’s annual meeting. This year’s recipient was Mr. Carl S. Armato, President and CEO of Novant Health in North Carolina.

The award was created by Costs of Care, a leading non-profit dedicated to curating and disseminating insights from the frontlines of health care to help delivery systems provide better care at lower cost, in conjunction with The Leapfrog Group, to recognize a hospital and/or health system CEO who has demonstrated courageous and ethical leadership addressing the twin issues of affordability and quality of health care in their community.

“Costs of Care believes that every health care CEO in the country should be focused tirelessly on patient safety and affordability. Health system leaders all face similar pressures and constraints, yet there are leaders like Carl Armato who are creating solutions to ensure patients receive safer and more affordable health care,” said Chris Moriates, MD, Executive Director of Costs of Care.

Mr. Armato has led the way in fostering a culture that is accessible and equitable by removing barriers for those seeking care within the communities that Novant Health serves. Under his leadership, the health system has taken significant steps to provide fair and transparent billing and pricing practices through innovative payment models that alleviate concerns and confusion about the cost of care. Mr. Armato has also strengthened Novant Health’s support for its most vulnerable communities by improving access to high-quality care through initiatives like its community health worker program, which helps address health disparities and socioeconomic determinants of health by connecting patients to important community resources and health education.

The Outstanding Healthcare CEO award is named in honor of Steven Schroeder, MD, Distinguished Professor of Health and Health Care at the University of California San Francisco and former President and CEO of the Robert Wood Johnson Foundation. Dr. Schroeder has spent five decades inspiring and mentoring leaders to forcefully advocate for better quality and more affordable health care, and he has inspired leaders of both Costs of Care and The Leapfrog Group.

Dr. Schroeder said about this year’s recipient, “In the face of pandemic-induced lost revenue by hospitals and medical systems, stewardship of medical resources requires visionary leadership and courage. That is why the programs led by Carl Armato of Novant Health are so important and worthy of celebration.”

“Novant Health exists to improve the health of our communities, one person at a time,” said Armato. “I am proud to receive this award on behalf of our health system for our continued commitment to removing barriers to care and improving health equity across all of our markets.”

“Even in the midst of the pandemic, great health system leaders have sustained their commitment to providing high-quality, affordable health care to their community,” said Leah Binder, president and CEO of The Leapfrog Group. “With this award we’re pleased to join with Costs of Care in recognizing a CEO who boldly faced the extraordinary circumstances of this year while simultaneously tackling patient safety, quality, and cost for patients.”

About Costs of Care

Costs of Care is a nonprofit organization dedicated to curating and broadly disseminating insights from the front lines of health care to help delivery systems provide better care at lower cost. Since 2009, Costs of Care has collected more than 500 personal accounts from physicians, nurses, and patients all over the United States that illustrate routine and high yield opportunities to improve the value of care delivery through improved decision-making. Costs of Care has created widely adopted and enduring resources to educate medical trainees and clinicians about how to address health care costs and provide high-value care, including the textbook Understanding Value-Based Healthcare, the “COST” framework for designing value improvement projects, multiple workshops, and free, CME-approved video modules. In December 2019, Costs of Care launched the Affordability Moonshot – envisioning a world in which “no one has to choose between their life and their life-savings” – paired with an Affordability Accelerator to support and collaborate on promising ideas to improve patient affordability.

Connect at https://costsofcare.org, be a part of the Moonshot at https://moonshot.costsofcare.org, and follow on Twitter @CostsOfCare.

About The Leapfrog Group

Founded in 2000 by large employers and other purchasers, The Leapfrog Group is a national nonprofit organization driving a movement for giant leaps forward in the quality and safety of American health care. The flagship Leapfrog Hospital Survey and new Leapfrog Ambulatory Surgery Center (ASC) Survey collect and transparently report hospital and ASC performance, empowering purchasers to find the highest-value care and giving consumers the lifesaving information they need to make informed decisions. The Leapfrog Hospital Safety Grade, Leapfrog’s other main initiative, assigns letter grades to hospitals based on their record of patient safety, helping consumers protect themselves and their families from errors, injuries, accidents, and infections.

Share article on social media or email:



RMA of Connecticut Spearheads Holidays at Home Initiative to Help Those Suffering with Infertility During the Holidays


RMA of Connecticut launches wellness video series

RMA of Connecticut to offer month-long virtual wellness program in Decemeber 2020

“The Integrated Fertility and Wellness team at RMA of Connecticut created this campaign to deliver actionable tips to those suffering through infertility during the holidays, providing additional support they can experience from the comfort of their homes.” – Amy Matton, RMA of Connecticut

RMA of Connecticut, a leading fertility practice whose exceptional quality and care helps couples and individuals grow their family, is spearheading a Holidays at Home social media initiative aimed at helping those suffering with infertility during the holidays. The month-long initiative will take place via RMA of Connecticut’s social media channels beginning Monday, December 7th.

The Integrated Fertility and Wellness team at RMA of Connecticut will share a short-form video series to combat unique fertility hurdles associated with those suffering with infertility and offer tactical ways to destress, move, eat, and breathe during the holiday season. The videos will be published in a rolling manner to RMA of Connecticut’s social channels from December 7th through December 10th, with the cumulative content to be reshared on their Learning Center blog at the end of the week.

Additionally, the RMA of Connecticut-produced podcast, FertilityU, will be releasing a special multi-interview podcast on December 18th to round out the Holidays at Home event. It will feature the Integrated Fertility and Wellness experts, sharing even more tips to overcoming feelings of anxiety, loneliness, and stress during this 2020 holiday season.

“Going through fertility treatments during the holidays can be a heavily emotional experience, and with COVID-19’s restrictions on family gatherings, this experience can seem even more isolating,” says Amy Matton, Acupuncturist and Director of the Integrated Fertility and Wellness Program. “The Integrated Fertility and Wellness team at RMA of Connecticut created this campaign to deliver actionable tips to those suffering through infertility during the holidays, providing additional support they can experience from the comfort of their homes.”

The Holidays at Home social media content includes:

Holidays at Home: Fertility Acupressure – Amy Matton, Acupuncturist, will guide viewers through the activation of the Shen men acupuncture point through acupressure, or physical pressure to an acupuncture point. This particular point helps relieve anxiety, fear, stress, among many other mental/emotional/nervous system responses.

Holidays at Home: Fertility-Friendly Holiday Swaps – Our in-house fertility Dietitian Nutritionist, Jill Hickey, walks patients through mindful holiday nutritional swaps. She offers alternatives to those traditional holiday beverages like hot cocoa and eggnog, helps us pack our plates for holiday dinners, and yes, she even digs into dessert!

Holidays at Home: Meditation for the Fertility Warrior – Lisa Rosenthal, RMA of Connecticut’s patient advocate and yoga instructor, takes the viewer through guided meditation, quieting stress and feelings of isolation, while increasing feelings of control and calmness.

Holidays at Home: Mood Shifting – Lisa Schuman, Director of Mental Health Services, offers a real way to calm feelings of stress and turns them in a more positive direction.

FertilityU Podcast Release: Holidays at Home with the IFW Team – Host and Reproductive Endocrinologist, Dr. Spencer Richlin, shares a podcast that features each Integrated Fertility and Wellness specialty. This compilation will be back-to-back short interviews with the Integrated Fertility and Wellness experts, highlighting even more tactics for feeling less stressed, anxious, or lonely during the holidays.

To view the Holidays at Home social media programming, visit our feeds on Facebook and Instagram (@fertility_rmact).

About Reproductive Medicine Associates of Connecticut (RMA of Connecticut)

RMA of Connecticut is a leader in fertility care, specializing in a range of infertility treatments. Our assisted reproductive technologies (ART) include intrauterine insemination (IUI), in-vitro fertilization (IVF) and pre-implantation genetic testing (PGT). RMA of Connecticut is Fairfield County’s largest fertility clinic and egg donation center. Through RMA of Connecticut’s Integrated Fertility and Wellness Center, we offer nutrition counseling, individual and couples psychological counseling, acupuncture and yoga, as well as financing and support services for our patients going through infertility treatment.

Our internationally recognized Gay Parents To Be® program at RMA of Connecticut specializes in LGBTQ family building. For the last four years, RMA of Connecticut has been recognized as a Leader in Healthcare Equality by the Human Rights Campaign.

Share article on social media or email:



ISPE Foundation Partners with Gilead Sciences on Internship Program to Diversify the Pharma Industry’s Workforce


The ISPE Foundation Diversity Internship Program interns will be immersed in creative and innovative projects, they will be connected with role models and senior leaders at Gilead, and they will be encouraged to let their imagination go to places they had not thought possible.

The ISPE Foundation and Gilead Sciences, Inc., have established the ISPE Foundation Diversity Internship Program to provide world-class opportunities to groups that are typically underrepresented in the pharmaceutical industry.

The ISPE Foundation Diversity Internship Program is a 12-week summer program that offers graduate students and undergraduate students in their junior or senior year the opportunity to spend their summer working on high-priority, impactful engineering and facilities projects and workstreams in Gilead’s Corporate Operations organization.

“It is a privilege to partner with Gilead on the launch of a program that will be truly life changing to the careers of a diverse pool of talented students and future leaders in the pharmaceutical field,” said Antonio Moreira, PhD, ISPE Foundation Board Chair, Vice Provost, Academic Affairs, University of Maryland Baltimore County. “The ISPE Foundation Diversity Internship Program interns will be immersed in creative and innovative projects, they will be connected with role models and senior leaders at Gilead, and they will be encouraged to let their imagination go to places they had not thought possible. I can’t think of a more inspiring and energizing way to start my role as the ISPE Foundation Chair.”

“Gilead is committed to investing in the next generation of engineers and are pleased to partner with the ISPE Foundation on this program,” said Joydeep Ganguly, Senior Vice President of Corporate Operations at Gilead. “We believe that diverse teams are inherently strong teams and look forward to the ways these interns will contribute to our highest priority projects.”

There are currently two summer internship opportunities available at Gilead within the Corporate Engineering and Facilities function:

  • Mechanical Engineering with Focus on Energy/Sustainability
  • Electrical Engineering with Focus on Process Control/Automation

The individuals in both internship roles will be expected to engage in a wide range of activities, such as creating standard equipment or discipline specifications with input from subject matter experts, developing standard installation details in AutoCAD as part of GEP, supporting various PI projects, e.g. checking on data integrity (non-GMP related work).

To learn more, please visit ISPEFoundation.org/Diversity-Internship-Program-Sponsored-Gilead.

About ISPE and ISPE Foundation

The International Society for Pharmaceutical Engineering (ISPE) is a not-for-profit association serving its 18,000+ Members through leading scientific, technical, and regulatory advancement across the entire pharmaceutical lifecycle. Founded in 2017 as the philanthropic arm of ISPE, the ISPE Foundation supports education, training, and research for the advancement of innovative technologies and provides solutions to global challenges in the development, manufacture, and supply of quality pharmaceutical products for the benefit of patients around the world. To aide in this endeavor, the Foundation focuses on initiatives related to increasing the technical knowledge of the incoming workforce, fostering diversity within the industry, and supporting efforts to bring quality pharmaceutical manufacturing to new markets. Visit ISPEFoundation.org for more information.

About Gilead Sciences

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California. Visit Gilead.com for more information.

Inquiries related to the program may be directed to:

Catherine Ford

Foundation Operations Manager

cford@ispe.org

Share article on social media or email:

Bluefin and 1-800 Notify Announce Partnership for Automated Healthcare Patient Phone Payments through Bluefin’s PayConex™ Gateway


“Partnering with 1-800 Notify provides our healthcare clients a huge value-added service for HIPAA and PCI compliant patient payments and communications,” said Greg Cornwell, Chief Revenue Officer, Bluefin.

Bluefin, the leader in encryption and tokenization payment and data security, and 1-800 Notify, the premier platform for HIPAA compliant automated phone payments (IVR), appointment reminders, billing reminders and notifications, have partnered to provide 1-800 Notify’s services through Bluefin’s PayConex™ gateway and Epic integration to leading healthcare organizations.

“Manually accepting a patient payment over the phone ties up already busy staff members, reducing their time to spend on more important and complicated patient requests,” said Martin Trautschold, Chief Executive Officer of 1-800 Notify. “We created the 1-800 Notify IVR Autopay by Phone system to seamlessly automate this task. Not only is the automated system 75% less expensive than a staff member, it is available 400% more time every week to accept patient calls 24/7, allowing patients to make payments on their schedule.”

“What’s even better is that with our Epic integration, patient balances are pulled directly from Epic and payments are posted to Epic in real-time, further reducing staff workload and increasing patient satisfaction,” added Mr. Trautschold.

Bluefin provides payment and data security technologies through the company’s PayConex gateway, including PCI-validated point-to-point encryption (P2PE) for the protection of point-of-sale (POS) card data and ShieldConex® for the tokenization of online card data, PII and PHI.

Bluefin is also integrated with Epic for payments and P2PE, enabling a secure payment experience for healthcare organizations utilizing the Epic platform. The 1-800 Notify solution also provides a seamless integration with Epic, enabling Bluefin’s clients to get integrated payments, P2PE and the 1-800 Notify service directly through PayConex and the PayConex/Epic integration.

“Partnering with 1-800 Notify provides our healthcare clients a huge value-added service for HIPAA and PCI compliant patient payments and communications,” said Greg Cornwell, Chief Revenue Officer, Bluefin. “Automating manual work and allowing patients to pay in a contactless remote manner are more important than ever because of the current pandemic, as much of the communication with patients has gone virtual. And the fact that 1-800 Notify is integrated with Epic means that our clients utilizing Blueifn’s PayConex / Epic integration can easily adopt this service through their current integration.”

“We are very excited to partner with the industry-leading, Bluefin PayConex platform and look forward to bringing the time-saving benefits of our industry-leading IVR Autopay by Phone system to more Bluefin clients in the future,” added Mr. Trautschold.

About Bluefin

Bluefin specializes in payment and data security technologies that protect point-of-sale (POS) and online transactions. Our security suite includes PCI-validated point-to-point encryption (P2PE) for contactless face-to-face, call center, mobile and unattended payments, and our ShieldConex® data security platform for the protection of personally Identifiable Information (PII), Personal Health Information (PHI), and payment data entered online. The company’s partner network currently includes over 135 processors, payment gateways and ISV’s operating in 34 countries, which provide Bluefin’s P2PE solutions direct to merchants, enterprises, healthcare organizations and more. Bluefin is a Participating Organization (PO) of the PCI Security Standards Council (SSC) and is headquartered in Atlanta, with offices in Waterford, Ireland. For more information, please visit http://www.bluefin.com.

About 1-800 Notify

1-800 Notify is a healthcare communications firm that is fully HIPAA and PCI compliant, an Epic App Orchard Partner and integrates with many systems. 1-800 Notify improves patient appointment attendance, wellness and payments while improving efficiency for hospitals, health systems, physician groups, and medical billing firms. Founded in 2011, 1-800 Notify has rapidly grown to support millions of inbound IVR autopay by phone calls, two-way appointment reminders, patient wellness and broadcast messages. 1-800 Notify is proud of its 98% client retention rate. We focus on learning each client’s unique needs, tailoring solutions to those needs and providing a highly reliable and scalable service — all at a price that is difficult for our competition to match. For more information, visit https://www.1800notify.com/.

Share article on social media or email:

Hip Arthroscopy Expert, Dr. Richard Seldes Reviewed & Approved By NJ Top Docs For 2020


Dr. Richard Seldes

Dr. Richard Seldes

We treat every patient as if they were our family member to ensure they have the safest, most efficient, state-of-the-art orthopedic care.

NJ Top Docs has reviewed and approved board-certified orthopedic surgeon, Dr. Richard Seldes for 2020. After completing his fellowship in total joint replacements of the hip, knee and shoulder at The Hospital For Special Surgery, Dr. Richard Seldes became one of the most sought after orthopedic surgeons in the tristate area.

Dr. Richard Seldes stays on the cutting-edge of orthopedic techniques and always incorporates the most beneficial treatments into his practice. A few recently integrated services include minimally invasive knee, hip and shoulder surgery, as well as robotic joint-replacement surgery.

Dr. Seldes’ expertise is always in high-demand as he is one of the area’s top experts in hip arthroscopy. He performs a high volume of total joint-replacement surgeries, including Mako robotic joint-replacement surgery.

“We treat every patient as if they were our family member to ensure they have the safest, most efficient, state-of-the-art orthopedic care,” Dr. Seldes says.

In addition, Dr. Seldes has continued to serve on the frontline during the COVID-19 crisis to treat patients with orthopedic emergencies throughout the tri-state area.

He has gone above and beyond to make sure patients feel safe returning to his office throughout the pandemic and has implemented multiple safety protocols. A few of these protocols include regular temperature checks, required PPE gear for all staff, and mandatory COVID-19 testing for all patients undergoing surgery. He is also offering telemedicine appointments for existing patients as needed.

To learn more about this NJ Top Doc, please visit: https://njtopdocs.com/nj-doctors/drrichardseldes/.

About Us

NJ Top Docs is a comprehensive, trusted and exclusive healthcare resource featuring reviewed and approved Top Doctors and Dentists in New Jersey online in an easy to use format. NJ Top Docs only reviews and approves providers based on merit after they have been extensively vetted.

NJ Top Docs is a division of USA Top Docs which allows patients to meet providers online before making their appointment.

For more information, please click here to contact us or visit http://www.NJTopDocs.com.

You can also follow us on Facebook, Twitter, & Instagram.

Share article on social media or email:



Offers Vaccine-Grade, Ultra-Low Frozen Storage


Thermo Scientific™ Forma™ FDE Series Ultra-Low Temperature GP Freezer

“By offering yet another temperature range service offering that is in high demand, we’re showing our current and future clients that Life Science Logistics is committed to being a one-stop shop for healthcare storage and distribution,” says LSL CEO Richard Beeny.

In response to ever-evolving demand for FDA-regulated, temperature-controlled storage and distribution of pharmaceutical and medical devices, Life Science Logistics (LSL), a leading, national provider of healthcare supply chain solutions, today announced the company plans to add ultra-low frozen storage to its extensive mix of life science product-related storage by the end of December 2020.

Driven by increasing demand for COVID-related and injectable drugs with “live” particulates requiring extreme freezes to preserve vaccine integrity, the company plans to add a significant number of -70-degree Celsius, ultra-low frozen storage ThermoFisher Scientific™ freezers and -25-degree Celsius ThermoFisher Scientific™ freezers to its 526,200 sq.ft. Brownsburg facility.

“By offering yet another temperature range service offering that is in high demand, we’re showing our current and future clients that Life Science Logistics is committed to being a one-stop shop for healthcare storage and distribution,” says LSL CEO Richard Beeny. “More than ever, the healthcare industry needs us to be nimble, creative and responsive as they explore new injectible trials and solutions for large-scale diseases.”

According to Beeny, the company had lots of requests pre- and during COVID for ultra-low frozen storage due to significant growth in injectible drugs for myriad diseases. He added that due to the sensitive nature of so many drugs, proper vaccine storage and handling is critical for efficacy of the products.

The company has two existing FDA-regulated storage and distribution facilities – a 526,200 sq. ft. Brownsburg facility and a 280,000 sq.ft. Whitestown facility. An additional Whitestown-based, 200,000 sq.ft. mixed-use storage facility, including cold-chain and controlled room temperature capabilities, is slated to open in early 2021.

About Life Science Logistics

Founded in 2006, DFW-based Life Science Logistics (LSL) is a leading, national provider of end-to-end, high-quality, customizable healthcare supply chain solutions. For clients ranging from Fortune 500 companies to startups, LSL offers its pharmaceutical, medical device, and biotech clients the ability to outsource services ranging from distribution to kitting to back- and middle-office functions. FDA-registered and VAWD-accredited, LSL operates from six locations totaling more than 2 million square feet of cGMP compliant space.

Share article on social media or email:

Pandemic prompts career transitions in the Gulf


Impact of Pandemic on Gulf Job Market

Impact of Pandemic on Gulf Job Market

The sharp drop in hiring activity resulting from the Covid-19 pandemic has forced many professionals in the Gulf to switch careers, according to the latest findings released by Middle East online recruitment firm, GulfTalent.

The study compared the trends in interview invitations received by jobseekers on GulfTalent.com website during the 9-month period from March to November 2020 against the same period in 2019. It found that the average number of interview invitations per active jobseeker was down by almost 50% for some segments of the market.

Winners and Losers

Among job categories, the drop in employment was most severe for teachers and catering professionals, seeing their interview invitations collapse by 48% and 35% respectively. Most other professions saw moderate drops in demand – including engineers and lawyers, followed by marketing, IT, finance and HR professionals.

Meanwhile, a handful of professions saw employment demand increase during the pandemic – notably medical staff who enjoyed a 19% increase in demand, followed by logistics professionals at 12%, thanks to the rapid growth of online shopping.

Sales professionals experienced a mixed impact, with those in telesales seeing a boost in demand due to the restrictions on travel and face-to-face meetings.

Among sectors of the economy, the biggest drop in hiring activity was in education, aviation and hospitality. The only sectors increasing hiring activity relative to the same period last year were healthcare and logistics.

In terms of location, professionals based locally within the Gulf saw a smaller impact from the pandemic. Interview invitations to candidates based in the UAE and Saudi Arabia dropped by 14% and 3% respectively, while those in Qatar saw interviews increase by 17% as employers were no longer able to fill vacancies with newly imported talent.

By contrast, candidates based in India and Pakistan seeking opportunities in the Gulf saw demand drops of 46% and 41% respectively, as flight cancellations and border closures brought international hiring to a standstill. A similar slowdown was experienced in hiring from Egypt and Lebanon, Arab countries that are common recruiting grounds for Gulf employers.

The pandemic has also resulted in a large drop in salaries, as the supply-demand balance has shifted in favour of employers. Analysis of vacancies posted on GulfTalent.com in the 9 months since the onset of the pandemic reveals an average 24% drop in salaries advertised, compared to the same period last year. The salary drop was greatest for professions most affected by the pandemic, such as teachers and chefs, while less affected roles saw smaller salary drops or no drop at all.

Career transitions

The economic squeeze brought about by the pandemic has resulted in job losses, pay cuts, salary delays and career stagnation for many expatriates in the Gulf. While many have left the region as a result, some have sought to retain their residence and earnings by switching to alternative careers within the region, according to GulfTalent’s findings.

Many cabin crew who lost their jobs have transitioned to real estate brokerage roles. Among teachers facing job losses or unpaid leave, admin and secretarial roles have been common destinations. Meanwhile, many catering professionals who were made redundant have taken up employment in customer service roles.

The pandemic has also pushed many into home-based freelance jobs or entrepreneurship. Some teachers reported for the first time teaching students privately from home via Zoom, while a small but growing number of people from different backgrounds are setting up online stores selling goods.

GulfTalent’s study was based on analysis of 2019 and 2020 hiring activity, including 6 million job applications submitted by jobseekers, 350,000 interview invitations issued by employers, and survey interviews with a sample of candidates.

About GulfTalent

GulfTalent is a leading online recruitment portal in the Middle East, covering 9 countries across the region. It is a key provider of both national and expatriate talent to over 10,000 employers across all industries, and is used by 9 million professionals and managers for finding top career opportunities in their field.

Media contact

Email: press@gulftalent.com | Tel: +971 4 278 5200

Share article on social media or email: